Rational design of thiazolidine-2,4-dione-integrated combretastatin A-4 analogues as potent and selective tubulin-targeting agents for triple-negative breast cancer
 
Yazarlar (1)
Doç. Dr. Feyzi Sinan TOKALI Kafkas Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı European Journal of Medicinal Chemistry (Q1)
Dergi ISSN 0223-5234 Dergi Bilgileri (2026)
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 12-2026
Kabul Tarihi 20-08-2026 Yayınlanma Tarihi 24-08-2026
Cilt / Sayı / Sayfa 319 / 1 / – DOI 10.1016/j.ejmech.2026.119270
Makale Linki https://doi.org/10.1016/j.ejmech.2026.119270
UAK Araştırma Alanları
Organik Kimya
Özet
Microtubule-targeting agents remain among the most effective chemotherapeutics for the treatment of cancer. Inspired by the natural tubulin polymerization inhibitor combretastatin A-4 (CA-4), a series of novel thiazolidine-2,4-dione derivatives was designed, synthesized, and evaluated as potential tubulin-targeting anticancer agents. The cytotoxic activities of the compounds were assessed against the MDA-MB-231, while human umbilical vein endothelial cells (HUVEC) were employed to evaluate selectivity. Compounds 2 and 3 emerged as the most active members of the series (IC 50 = 3.60 and 3.71 μM, respectively), accompanied by remarkably high selectivity indices of 49.7 and 51.3. To elucidate their mechanism of action, compounds 2 and 3 were further evaluated in an in vitro tubulin polymerization assay. Compound 3 displayed the strongest inhibitory activity (IC 50 = 1.07 μM), surpassing the ...
Anahtar Kelimeler
Breast cancer | Combretastatin A-4 | Inhibition | Thiazolidine-2,4-dione | Tubulin polymerization